drugset / Trial / NCT04946734

Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine

NCT04946734

Phase 3 Active not recruiting 440 enrolled Guangdong Provincial People's Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Effectivity and safety of PFO closure vs medicine in alleviating migraine (SPRING): a multicenter, random, case control study

Timeline

Start
2021-08-12
Primary completion
2025-09-06
Completion
2025-09-06

Drugs

EvaluationDrugModalityDoseRoute
Background Aspirin Small molecule 100 mg
Background Clopidogrel Small molecule 75 mg